1. Home
  2. OESX vs PYPD Comparison

OESX vs PYPD Comparison

Compare OESX & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OESX

Orion Energy Systems Inc.

N/A

Current Price

$31.26

Market Cap

103.4M

ML Signal

N/A

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

N/A

Current Price

$5.43

Market Cap

107.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OESX
PYPD
Founded
1996
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Building Products
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.4M
107.0M
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
OESX
PYPD
Price
$31.26
$5.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
★ $36.50
$11.75
AVG Volume (30 Days)
69.3K
★ 78.9K
Earning Date
11-04-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.47
N/A
Revenue
★ $86,306,000.00
N/A
Revenue This Year
$17.95
N/A
Revenue Next Year
$10.38
N/A
P/E Ratio
$65.13
★ N/A
Revenue Growth
★ 8.26
N/A
52 Week Low
$7.88
$3.06
52 Week High
$31.32
$5.73

Technical Indicators

Market Signals
Indicator
OESX
PYPD
Relative Strength Index (RSI) 66.26 56.33
Support Level $8.98 $4.15
Resistance Level $31.00 $5.59
Average True Range (ATR) 1.80 0.23
MACD -0.10 -0.01
Stochastic Oscillator 82.71 76.44

Price Performance

Historical Comparison
OESX
PYPD

About OESX Orion Energy Systems Inc.

Orion Energy Systems Inc provide light emitting diode (LED) lighting systems, wireless Internet of Things (IoT) enabled control solutions, commercial and industrial electric vehicle charging infrastructure solutions and lighting and electrical maintenance services. It help its customers achieve their sustainability, energy savings and carbon footprint reduction goals through technology and exceptional service. It sell its products and services into many vertical markets within the broader commercial and industrial market segment. Primary verticals include box retail, manufacturing, warehousing/logistics, federal and municipal government, healthcare and schools. It has three segments Lighting, Maintenance, and EV segment. It generates majority of revenue from Lighting segment.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: